Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
zhenzhu diwan
- Development stage
- Unknown
- Lead developer
- Guizhou Yibai Pharmaceutical
- Modality
- Peptides, Small Molecules
- Administration
- Topical, Oral
01
Overview
Zhenzhu Diwan is a Traditional Chinese Medicine (TCM) dropping pill formulation developed and manufactured by Guizhou Yibai Pharmaceutical Co., Ltd. for the treatment of recurrent aphthous ulcers (RAU). The formulation is composed of active ingredients including pearl powder (Margarita), indigo naturalis (Qingdai), and borneol (Bingpian). It functions by reducing local inflammation, providing analgesic relief, and promoting the regeneration of the oral mucosal epithelium. The dropping pill dosage form allows for high local drug concentration and prolonged contact with the ulcerated area, facilitating rapid healing and pain reduction. It is widely used in China for various forms of stomatitis and oral ulcerations and is registered as a pharmaceutical product under the National Medical Products Administration (NMPA).
- Brand names
- Zhenzhu Diwan
- Other names
- Pearl Dropping Pills
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on zhenzhu diwan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on zhenzhu diwan.